Nutrastar International Inc Files Patent Application for Golden Grass Wine and Golden Grass Oral Liquids

Tuesday, August 10, 2010 Corporate News
Email Print This Page Comment bookmark
Font : A-A+

HARBIN, China, Aug. 10 Nutrastar International, Inc.(OTC Bulletin Board: NUIN; "Nutrastar" or the "Company"), a leadingnutraceutical company which produces and distributes Chinese Golden Grass("Cordyceps Militaris"), today announced that it has recently filed a patentapplication for the production process related to mass producing Golden Grasswine and Golden Grass oral liquids.

After years of R&D efforts, the Company is pleased to announce that it hassuccessfully developed and mastered the techniques required to produce GoldenGrass wine and Golden Grass oral liquids. These Golden Grass productscurrently are in very high demand and have substantial growth potential in theTraditional Chinese Medicine (TCM) market. They are widely accepted in Chineseculture for their unique medicinal benefits including strengthening the immunesystem and combating the harmful effects of fatigue and aging. The Companyanticipates trial production will begin in first quarter of 2011. Onceapproved and available for sale to the public, the Company expects theirGolden Grass wine and oral liquids products to be a significant growthcatalyst going forward.

Ms. Lianyun Han, Founder and Chief Executive Officer of Nutrastarcommented, "I would like to thank our highly dedicated R&D team for allowingNutrastar to bring such highly popular products, Golden Grass wine and GoldenGrass oral liquids, to the TCM market. We are very excited to add theseproducts to our growing pipeline and look forward to additional applicationsfrom our R&D team."

About Nutrastar International, Inc.

Nutrastar International, Inc. is a China based nutraceutical company whichproduces and distributes Chinese Golden Grass ("Cordyceps Militaris"), organicand specialty food products in China. The Company's primary product is dryengineered Chinese Golden Grass, which is one of the most highly regardedherbal nutrients in Chinese culture. The Company believes it is the largestmanufacturer of engineered Chinese Golden Grass in China, ranked by volume,according to China Market Monitoring Center (CMMC), accounting for 19% marketshare in China. The Company is headquartered in Harbin, capital ofHeilongjiang province, with 302 employees, 21 in R&D, and 132 in sales andmarketing. The products of Nutrastar are sold throughout China via adistribution network that covers more than 10 provinces. More information maybe found at or e-mail: .

Safe Harbor Statement

This news release contains forward-looking statements. Forward-lookingstatements include statements concerning plans, objectives, goals, strategies,future events or performance, and underlying assumptions and other statementsthat are other than statements of historical facts. These statements aresubject to uncertainties and risks including, but not limited to, product andservice demand and acceptance, changes in technology, economic conditions, theimpact of competition and pricing, government regulation, and other riskscontained in reports filed by the Company with the Securities and ExchangeCommission. All such forward-looking statements, whether written or oral, andwhether made by or on behalf of the Company, are expressly qualified by thecautionary statements and any other cautionary statements which may accompanythe forward-looking statements. You should not place undue reliance on theseforward-looking statements, which speak only as of the date of this pressrelease. Other than as required under the securities laws, the Company doesnot assume a duty to update any forward-looking statements to reflect eventsor circumstances after the date hereof.For more information, please contact: Robert Tick CFO Nutrastar International, Inc. Tel: +1-408-306-9881 Email: Howard Gostfrand American Capital Ventures Tel: +1-305-918-7000 Email:

SOURCE Nutrastar International, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store